Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Riccardo MoiaRiccardo DondolinMaria Stefania De ProprisDonatella TalottaSamir MouhssineFrancesca PerutelliGianluigi RedaVeronica MattielloGian Matteo RigolinMarina MottaJacopo OlivieriRenato FaninOmar PerbelliniIsacco FerrariniFrancesca Romana MauroIlaria Del GiudiceLuca LaurentiAnnamaria TomassoMassimo GentileAnna Maria FrustaciAlessandra TedeschiAlessandro GozzettiCaterina StelitanoChiara RusconiCarol MorenoFrancesco ForconiRoberto MarascaMarta CosciaDavide RossiRobin FoàGianluca GaidanoPublished in: Hematological oncology (2022)